Popular GLP-1 weight-loss drugs like Ozempic and Zepbound can help reduce a woman's risk for as many as 14 cancers associated ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

A doctor has warned of the 'multitude of factors' which could risk any long-term results once someone stops taking Ozempic.

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Based on animal studies, it’s thought that Ozempic may increase your risk of thyroid cancer. It’s important to note that animal studies don’t always predict what will happen in humans.

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Mounjaro, Ozempic and other fat-melting injections ... no medications have been proven to lower the cancer risk associated with obesity. 'Our study begins to fill that gap by evaluating GLP ...

Saxenda and Ozempic have a boxed warning for risk of thyroid cancer. A boxed warning is a serious warning from the FDA. To learn more, see the “Precautions for Saxenda and Ozempic” section.

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...

An Ozempic Expert Explains What You Need to Know ... finding a difference and others not finding a difference in cancer risk—seemed to come from the fact that some studies do what we did ...